Expertise in
10
conditions

Martin S. Dyer

Leicester, ENG, GB 
Expertise in
10
conditions
Leicester, ENG, GB 

Overview

Martin Dyer practices practicing medicine in Leicester, United Kingdom.

Mr. Dyer is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), and Diffuse Large B-Cell Lymphoma (DLBCL).

He is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Leicester, ENG LE19HN, United Kingdom
Other Locations
Liverpool, ENG L697ZD, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Open-Label Single-Arm Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-2)
A Phase 2 Open-Label Single-Arm Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-2)
Enrollment Status: Completed
Publish Date: August 29, 2023
Intervention Type: Drug
Study Drug: Loncastuximab tesirine
Study Phase: Phase 2
A Cancer Research UK Phase I Trial of AZD3965, a Monocarboxylate Transporter 1 Inhibitor (MCT1) in Patients With Advanced Cancer
A Cancer Research UK Phase I Trial of AZD3965, a Monocarboxylate Transporter 1 Inhibitor (MCT1) in Patients With Advanced Cancer
Enrollment Status: Completed
Publish Date: April 11, 2022
Intervention Type: Drug
Study Drug: AZD3965
Study Phase: Phase 1
A Cancer Research UK Phase I/IIa Clinical Trial of BI-1206; an Antibody to FcƔRIIB (CD32b), as a Single Agent and in Combination With an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Malignancy
A Cancer Research UK Phase I/IIa Clinical Trial of BI-1206; an Antibody to FcƔRIIB (CD32b), as a Single Agent and in Combination With an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Malignancy
Enrollment Status: Completed
Publish Date: July 08, 2021
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

99 Total Publications

More than an attachment module: covalent inhibitor warheads influence BTK dynamics and function.
More than an attachment module: covalent inhibitor warheads influence BTK dynamics and function.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026

Frequently Asked Questions about Martin S. Dyer

Is Martin S. Dyer a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Martin S. Dyer is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin S. Dyer participate in research or clinical trials?

Yes. Martin S. Dyer has published 99 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Martin S. Dyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dyer's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile